drugset / Trial / NCT00729495
Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib
RandomizedSingle-groupOpen-label
Summary
Phase I study designed to test the hypothesis that overencapsulated celecoxib 200 mg qd is bioequivalent to commercial celecoxib 200 mg qd. Approximately 90 healthy volunteers will be randomized to yield approximately 80 completers. The study is an open label, randomized, 2-way crossover with single dosing followed by a 7-day washout period between treatment arms
Timeline
- Start
- 2008-07
- Primary completion
- 2008-08
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 200 mg | Oral |
Indications
No indication recorded.